Cargando…

Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration – a MACUSTAR study report

BACKGROUND/AIMS: To further validate the Vision Impairment in Low Luminance (VILL) questionnaire, which captures visual functioning and vision-related quality of life (VRQoL) under low luminance, low-contrast conditions relevant to age-related macular degeneration (AMD). METHODS: The VILL was transl...

Descripción completa

Detalles Bibliográficos
Autores principales: Terheyden, Jan Henrik, Pondorfer, Susanne G, Behning, Charlotte, Berger, Moritz, Carlton, Jill, Rowen, Donna, Bouchet, Christine, Poor, Stephen, Luhmann, Ulrich F O, Leal, Sergio, Holz, Frank G, Butt, Thomas, Brazier, John E, Finger, Robert P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359508/
https://www.ncbi.nlm.nih.gov/pubmed/35354561
http://dx.doi.org/10.1136/bjophthalmol-2021-320848
_version_ 1785075898712588288
author Terheyden, Jan Henrik
Pondorfer, Susanne G
Behning, Charlotte
Berger, Moritz
Carlton, Jill
Rowen, Donna
Bouchet, Christine
Poor, Stephen
Luhmann, Ulrich F O
Leal, Sergio
Holz, Frank G
Butt, Thomas
Brazier, John E
Finger, Robert P
author_facet Terheyden, Jan Henrik
Pondorfer, Susanne G
Behning, Charlotte
Berger, Moritz
Carlton, Jill
Rowen, Donna
Bouchet, Christine
Poor, Stephen
Luhmann, Ulrich F O
Leal, Sergio
Holz, Frank G
Butt, Thomas
Brazier, John E
Finger, Robert P
author_sort Terheyden, Jan Henrik
collection PubMed
description BACKGROUND/AIMS: To further validate the Vision Impairment in Low Luminance (VILL) questionnaire, which captures visual functioning and vision-related quality of life (VRQoL) under low luminance, low-contrast conditions relevant to age-related macular degeneration (AMD). METHODS: The VILL was translated from German into English (UK), Danish, Dutch, French, Italian and Portuguese. Rasch analysis was used to assess psychometric characteristics of 716 participants (65% female, mean age 72±7 years, 82% intermediate AMD) from the baseline visit of the MACUSTAR study. In a subset of participants (n=301), test–retest reliability (intraclass correlation coefficient (ICC) and coefficient of repeatability (CoR)) and construct validity were assessed. RESULTS: Four items were removed from the VILL with 37 items due to misfit. The resulting Vision Impairment in Low Luminance with 33 items (VILL-33) has three subscales with no disordered thresholds and no misfitting items. No differential item functioning and no multidimensionality were observed. Person reliability and person separation index were 0.91 and 3.27 for the Vision Impairment in Low Luminance Reading Subscale (VILL-R), 0.87 and 2.58 for the Vision Impairment in Low Luminance Mobility Subscale (VILL-M), and 0.78 and 1.90 for the Vision Impairment in Low Luminance Emotional Subscale (VILL-E). ICC and CoR were 0.92 and 1.9 for VILL-R, 0.93 and 1.8 for VILL-M and 0.82 and 5.0 for VILL-E. Reported VRQoL decreased with advanced AMD stage (p<0.0001) and was lower in the intermediate AMD group than in the no AMD group (p≤0.0053). CONCLUSION: The VILL is a psychometrically sound patient-reported outcome instrument, and the results further support its reliability and validity across all AMD stages. We recommend the shortened version of the questionnaire with three subscales (VILL-33) for future use. TRIAL REGISTRATION NUMBER: NCT03349801.
format Online
Article
Text
id pubmed-10359508
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-103595082023-07-22 Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration – a MACUSTAR study report Terheyden, Jan Henrik Pondorfer, Susanne G Behning, Charlotte Berger, Moritz Carlton, Jill Rowen, Donna Bouchet, Christine Poor, Stephen Luhmann, Ulrich F O Leal, Sergio Holz, Frank G Butt, Thomas Brazier, John E Finger, Robert P Br J Ophthalmol Clinical Science BACKGROUND/AIMS: To further validate the Vision Impairment in Low Luminance (VILL) questionnaire, which captures visual functioning and vision-related quality of life (VRQoL) under low luminance, low-contrast conditions relevant to age-related macular degeneration (AMD). METHODS: The VILL was translated from German into English (UK), Danish, Dutch, French, Italian and Portuguese. Rasch analysis was used to assess psychometric characteristics of 716 participants (65% female, mean age 72±7 years, 82% intermediate AMD) from the baseline visit of the MACUSTAR study. In a subset of participants (n=301), test–retest reliability (intraclass correlation coefficient (ICC) and coefficient of repeatability (CoR)) and construct validity were assessed. RESULTS: Four items were removed from the VILL with 37 items due to misfit. The resulting Vision Impairment in Low Luminance with 33 items (VILL-33) has three subscales with no disordered thresholds and no misfitting items. No differential item functioning and no multidimensionality were observed. Person reliability and person separation index were 0.91 and 3.27 for the Vision Impairment in Low Luminance Reading Subscale (VILL-R), 0.87 and 2.58 for the Vision Impairment in Low Luminance Mobility Subscale (VILL-M), and 0.78 and 1.90 for the Vision Impairment in Low Luminance Emotional Subscale (VILL-E). ICC and CoR were 0.92 and 1.9 for VILL-R, 0.93 and 1.8 for VILL-M and 0.82 and 5.0 for VILL-E. Reported VRQoL decreased with advanced AMD stage (p<0.0001) and was lower in the intermediate AMD group than in the no AMD group (p≤0.0053). CONCLUSION: The VILL is a psychometrically sound patient-reported outcome instrument, and the results further support its reliability and validity across all AMD stages. We recommend the shortened version of the questionnaire with three subscales (VILL-33) for future use. TRIAL REGISTRATION NUMBER: NCT03349801. BMJ Publishing Group 2023-08 2022-03-30 /pmc/articles/PMC10359508/ /pubmed/35354561 http://dx.doi.org/10.1136/bjophthalmol-2021-320848 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Science
Terheyden, Jan Henrik
Pondorfer, Susanne G
Behning, Charlotte
Berger, Moritz
Carlton, Jill
Rowen, Donna
Bouchet, Christine
Poor, Stephen
Luhmann, Ulrich F O
Leal, Sergio
Holz, Frank G
Butt, Thomas
Brazier, John E
Finger, Robert P
Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration – a MACUSTAR study report
title Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration – a MACUSTAR study report
title_full Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration – a MACUSTAR study report
title_fullStr Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration – a MACUSTAR study report
title_full_unstemmed Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration – a MACUSTAR study report
title_short Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration – a MACUSTAR study report
title_sort disease-specific assessment of vision impairment in low luminance in age-related macular degeneration – a macustar study report
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359508/
https://www.ncbi.nlm.nih.gov/pubmed/35354561
http://dx.doi.org/10.1136/bjophthalmol-2021-320848
work_keys_str_mv AT terheydenjanhenrik diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT pondorfersusanneg diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT behningcharlotte diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT bergermoritz diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT carltonjill diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT rowendonna diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT bouchetchristine diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT poorstephen diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT luhmannulrichfo diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT lealsergio diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT holzfrankg diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT buttthomas diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT brazierjohne diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT fingerrobertp diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport
AT diseasespecificassessmentofvisionimpairmentinlowluminanceinagerelatedmaculardegenerationamacustarstudyreport